Taclonex NDC 50222-501

NDC codes

FDA NDC Directory

Product NDC (as listed)50222-501Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50222-0501Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50222-501-06	50222050106	40 CARTON in 1 CASE (50222-501-06) / 1 BOTTLE in 1 CARTON / 60 g in 1 BOTTLEMarketed from Jun 1, 2008
50222-501-66	50222050166	10 PACKAGE in 1 BOX (50222-501-66) / 2 BOTTLE in 1 PACKAGE / 60 g in 1 BOTTLEMarketed from Jun 1, 2008

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Taclonex
Generic name (nonproprietary): calcipotriene and betamethasone dipropionate
Active ingredients: Calcipotriene hydrate — 50 ug/gBetamethasone dipropionate — .5 mg/g
Dosage form: Suspension
Route: Topical
Labeler: LEO Pharma Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 022185
Marketing start: Jun 1, 2008
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)Vitamin D (Chemical structure)
Identifiers: Product ID 50222-501_5d56e57e-6b91-4916-96d8-6dca1af7487dSPL ID 5d56e57e-6b91-4916-96d8-6dca1af7487dSPL set ID 757c914f-dd8d-43cc-a973-212d591af4afRxCUI 833461, 833463UNII S7499TYY6G, 826Y60901U
Pharmacologic class: Corticosteroid; Vitamin D Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450222050106 followed by a unit qualifier and the quantity

Package 50222-0501-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 30, 2017.

Indications (excerpt from the label)

Taclonex ® Topical Suspension is indicated for the topical treatment of plaque psoriasis of the scalp and body in patients 12 years and older. Taclonex Topical Suspension is a combination of calcipotriene, a vitamin D analog, and betamethasone dipropionate, a corticosteroid, indicated for the topical treatment of plaque psoriasis of the scalp and body in patients 12 years and older. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)